Cargando…
ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome
BACKGROUND: ErbB2 is a member of the epidermal growth factor family of tyrosine kinases that is centrally involved in the pathogenesis of prostate cancer and several studies have reported that a high expression of this protein has prognostic value. In the present study, we have investigated whether...
Autores principales: | Hammarsten, Peter, Winther, Johanna, Rudolfsson, Stina H., Häggström, Jenny, Karalija, Amar, Egevad, Lars, Granfors, Torvald, Fowler, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162542/ https://www.ncbi.nlm.nih.gov/pubmed/25215939 http://dx.doi.org/10.1371/journal.pone.0105063 |
Ejemplares similares
-
Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression
por: Hammarsten, Peter, et al.
Publicado: (2012) -
Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB(1) Receptor Expression and Regulation by IL-4
por: Thors, Lina, et al.
Publicado: (2010) -
Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
por: Hammarsten, Peter, et al.
Publicado: (2019) -
Role of ErbB Receptors in Cancer Cell Migration and Invasion
por: Appert-Collin, Aline, et al.
Publicado: (2015) -
The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017)